Surfing the MASH Tsunami
Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL
Surfing the MASH Tsunami
S2-E9.2—Drug-Free Treatment of Early Fatty Liver Disease: Issues for Public Health
Donna Cryer joins the Surfers to consider some of the public health issues and implications surrounding treatment of Early Fatty Liver disease and related metabolic diseases. EXTRA: Louise Campbell discusses her public health-driven motivation to form Tawazun Health.
This episode is sponsored by Echosens. Echosens is partnering with Chronwell and ModifyHealth to offer LIVErHEALTHY, an integrated program of non-invasive monitoring, technology-supported behavior support, nutritional counseling and delivery of medically-tailored meals.
After focusing solely on identify and motivation, the Surfers switch focus to consider public health issues. Donna Cryer discusses specific challenges linked to diet and education that Public Health could address better. Louise Campbell describes her motivation in forming Tawazun Health to provide education and feedback for those who lacked the insight necessary to take better care of themselves, while Stephen Harrison links these issues to how he treats patients today.